Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Flexible Dose, Single Site Study Evaluating the Safety, Efficacy and Tolerability of Cariprazine as an Adjunct to Psychostimulants in Adult Patients With ADHD Who Have Had an Inadequate Response to Psychostimulants Alone

NCT04843423 is registered in ClinicalTrials.gov with Dr. Martin A. Katzman as lead sponsor.

NCT NCT04843423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04843423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Flexible Dose, Single Site Study Evaluating the Safety, Efficacy and Tolerability of Cariprazine as an Adjunct to Psychostimulants in Adult Patients With ADHD Who Have Had an Inadequate Response to Psychostimulants Alone
Lead sponsor
Dr. Martin A. Katzman
Phase
Phase 4
Overall status
Unknown status
Start date
December 1, 2021
Completion date
April 14, 2023
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder